Ertapenem Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 16714-889

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ertapenem Sodium (NDC 16714-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of Ertapenem Sodium, the active ingredient in ERTAPENEM SODIUM injection, powder, lyophilized, for solution. The structure shows detailed molecular bonds including a beta-lactam ring, sulfur atoms, carboxyl groups, and a sodium ion associated with the carboxylate group.*

FDA Label Image

Label (Label)

Label for Ertapenem for Injection 1 g/Vial from NorthStar RxLLC. The lyophilized powder is for intravenous or intramuscular use and comes as a single-dose vial. The label includes product details, inactive ingredients, storage instructions, manufacturer information, and a barcode.*

FDA Label Image

Carton (Carton)

Ertapenem for Injection 1 g/Vial powder for solution, for intravenous or intramuscular use. The label shows packaging for 10 single dose vials by NorthStar RxLLC. The label includes instructions for reconstitution and storage, inactive ingredients, and manufacturer information, including GLAND PHARMA LIMITED in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.